Patient Journey Mapping: Diagnosis to Treatment
Where patients leak — and where to intervene.
A decision-grade approach to mapping the patient journey from symptom onset to treated outcome — for launch, access, and digital-health strategy.
"Where in the journey is the patient leak — and where can we intervene with the highest leverage?"
Patient journey mapping isn’t a slide deck; it’s a quantified funnel that shows where patients are lost and where intervention has the highest commercial and clinical impact.
Patient journey mapping is the difference between launch decks and launch results. The goal isn’t to draw a swim lane — it’s to quantify every transition between symptom and outcome and find where intervention has the most leverage.
Five stages, every leak measured
Symptom → presentation → diagnosis → treatment → adherence → outcome. Quantify each. The largest absolute drop-off — usually diagnosis or adherence — is where pharma resources, digital tools and HCP programs should concentrate.
Operate the journey as a live system
Hard-wired into RWE feeds, the journey becomes a continuously updated funnel showing what worked and what didn’t — not a one-time deliverable.
What we’re seeing in the data.
Diagnosis is the largest leak
For most chronic conditions, less than half of prevalent cases are diagnosed.
Specialist referral compresses TAM further
Referral times, panel availability and geographic specialist density cap reach.
Adherence drops 50% by year two
Real-world adherence to chronic therapy halves from launch to year two without active patient programs.
Digital tools can close measurable gaps
Digital triage, RPM and adherence platforms have published outcomes data showing 10–30% leak reduction.
How to think about it.
-
01
Define journey stages
Symptom → presentation → diagnosis → referral → treatment → adherence → outcome.
-
02
Quantify each stage
Use claims, EHR and registry data to size every transition.
-
03
Identify the leak hotspots
Find the stages with the largest absolute drop-off.
-
04
Intervene with measurable programs
Targeted patient education, HCP programs, digital triage, RPM, HUB services.
-
05
Tie back to RWE
Use post-launch real-world data to prove leak reduction.
What separates a good answer from a defensible one.
Country and even state-level journeys differ — don’t collapse them.
Multi-morbid patients distort single-condition journeys.
Where the diagnosis happens shapes intervention design.
GDPR/HIPAA constraints shape data join feasibility.
Where the signal comes from.
Common questions.
How granular should the journey be?
Stage-level for strategy; touchpoint-level (HCP visits, prescriptions, refills) for tactical execution.
Can AI improve patient journey insight?
Yes — pattern-mining on EHR/claims surfaces non-obvious drop-off patterns and predicts patient leak risk.
Want this answered on your data?
We build decision systems on top of analyses like this — so the next question takes minutes, not weeks.
Talk to a strategist